Documents

 

Hulpmiddelen

ALIFE2 Flowchart

ALIFE2 Randomisatie instructies

of klik direct op de link: https://nl.tenalea.net/amc/ALEA/

ALIFE2 inclusie instructies 

Dagboekje

Patient journal (English)

Journal du patient (French patient journal) 

ALIFE2 huisartsenbrief

Advies antistolling post-partum 

Advies peripartum

ALIFE2 drug accountability form 

 

CRF

CRF ALIFE2


Registratie/Registration

Registratie formulier

Registration form


Protocol

ALIFE2 protocol V6.0

ABR formulier ALIFE2 V09

 

METC

METC goedkeuring protocol V6.0

ALIFE2 METC goedkeuring AMC OLVG VUMC LUMC Isala

ALIFE2 METC goedkeuring UMCN

ALIFE2 METC goedkeuring UMCG

ALIFE2 METC goedkeuring MMC

ALIFE2 METC goedkeuring JBZ

ALIFE2 METC goedkeuring Tergooi

ALIFE2 onderzoeksverklaring AMC april 2012

 

Raad van bestuur

ALIFE2 aanbiedingsbrief RvB

ALIFE2 goedkeuring RvB AMC 31 augustus 2012

ALIFE2 goedkeuring RvB UMCN St. Radboud

ALIFE2 goedkeuring RvB LUMC

ALIFE2 goedkeuring RvB Isala Klinieken

ALIFE2 goedkeuring RvB UMCG

ALIFE2 goedkeuring RvB OLVG

ALIFE2 goedkeuring RvB JBZ

ALIFE2 goedkeuring RvB MMC

 

PatiŽnteninformatie per centrum

ALIFE2 PIF AMC

ALIFE2 PIF LUMC V3

ALIFE2 PIF Isala klinieken V3

ALIFE2 PIF OLVG V3

ALIFE2 PIF UMCG V3

ALIFE2 PIF UMCN V3

ALIFE2 PIF UMCU

ALIFE2 PIF JBZ

ALIFE2 PIF MMC

ALIFE2 PIF Amphiaziekenhuis

 

Overig

ALIFE2 declaratieformulier inclusievergoeding

ALIFE2 monitoringplan

ALIFE2 presentatie

flowchart ALIFE2

 

Adjudication forms

Adjudication form Easy bruising

Adjudication form Bleeding

Adjudication form HIT

Adjudication form Allergic reaction

Adjudication form VTE

Adjudication form Congenital anomaly

Adjudication form Placental abruption

Adjudication form Preeclampsia & HELLP

Adjudication form Mortality

 

Summary of product characteristics

ALIFE2 SPC nadroparine

ALIFE2 SPC enoxaparine

ALIFE2 SPC dalteparine

ALIFE2 SPC tinzaparine